Lives on the Line: How Williamson County, TN, Bioscience Is Changing Medicine

Warren Center for Neuroscience Drug Discovery

Williamson County has long been known as a thriving economic hub, home to major global brands. But now, some of the county’s newest innovators are developing technologies with the potential to save lives.

Two institutions now working in Franklin are putting Williamson County on the bioscience map in ways that reach far beyond Middle Tennessee.

Spot On: Dxcover’s Early Cancer Detection

Dxcover Limited, a Scotland-based diagnostics company focused on early cancer detection, has opened its U.S. headquarters in Franklin. The company – pronounced “discover” – brings with it a technology that could fundamentally change how cancer is caught and treated.

Dxcover’s PANAROMIC™ Platform uses infrared spectroscopy and machine-learning-derived algorithms to identify cancer-specific patterns in proteins, lipids, carbohydrates and other components of a tiny blood sample, delivering results within 25 minutes of sample preparation.

Drop. Dry. Detect.

The approach is elegant in its simplicity: Drop. Dry. Detect. It is a cost-effective, noninvasive platform that captures the complete biological signature from a minute volume of blood.

In a large-scale study of more than 2,000 patients, the technology demonstrated the ability to detect eight different cancer types – including brain, colorectal, lung, ovarian, pancreatic and prostate – through a single blood test.

For cancers like ovarian and pancreatic, which are notoriously difficult to detect early and carry some of the lowest survival rates, that kind of detection can be lifesaving.

“We are thrilled to join the vibrant community of Franklin and contribute to the growth of both the local economy and the healthcare sector,” Matthew Baker, CEO of Dxcover, said in a press release. “Our new clinical laboratory location will allow us to expand our operations into the U.S. and launch our cutting-edge, blood-based screening technologies to patients nationwide as we work to transform how cancer is detected and treated.”

The company plans to roll out its brain cancer test in the European Union and the United Kingdom this year, with U.S. commercialization targeted for 2027.

Developing History: The Warren Center for Neuroscience Drug Discovery

Nearby, at Cool Springs Innovation Park, another kind of groundbreaking science is underway.

The Warren Center for Neuroscience Drug Discovery (WCNDD) – a clinical-stage biotech enterprise within Vanderbilt University – is rewriting what’s possible for people living with some of the most devastating neurological conditions known to medicine.

The center is dedicated to finding effective treatments for neurological conditions, including Parkinson’s, Alzheimer’s, addiction and schizophrenia, conditions that affect millions worldwide.

From the Lab to Clinical Trials

Under the leadership of Executive Director Craig Lindsley, about 100 scientists work across 25 active research projects, with six compounds already in Phase I clinical trials and one advanced to Phase II with patients – a pace described as unmatched among academic drug discovery institutions.

Academic research centers typically hand off promising discoveries to pharmaceutical companies for the long, expensive march to human testing. The WCNDD does it itself.

“We thought we were going to be making tool molecules, doing a lot of deep basic science, and then maybe encouraging other folks in industry to pursue those targets and actually make the drugs,” Lindsley says. “And in the course of that exercise, we actually just kept advancing and making further advancements. Then we started doing clinical trials on our own.”

Lindsley says the WCNDD’s work is significant. “To build a drug discovery enterprise in Williamson County to rival what is commonplace on the East and West coasts is exciting, and to develop new drugs that treat Parkinson’s, schizophrenia and Alzheimer’s here is groundbreaking,” he says. “Williamson County and the state of Tennessee stand on the precipice of a new wave of biotechnology that will impact its citizens and the world.”

Together, Dxcover and the Warren Center represent something Williamson County has been quietly building toward – a bioscience identity that complements its corporate headquarters legacy and shapes a healthier future.